2Itoh H, Ogata H, Yamamoto M, et al. Comparison of oral faleealeitriol and intrarenous caleitriol in hemodialysis patients with secondary hyper - parathyroidism: a randomized crossover [J]. Clin Nephrol, 2009, 71 (6) : 660 -668.
3Bolasco P. Effects of the use of non - calcium phosphate binders in the control and outcome of vascular calcifications : A review of clinical trials on CKD patients [J]. Int J Nephrol, 2011 (2011) : 758450.
4Mittman N, Desiraju B, Meyer KB. Treatment of secondary hyper - parathyroidism in ESRD: a 2 - year, single - center crossover study[J]. Kidney Int Suppl, 2010 (117) : 33 -36.
5Mariano Rodriguez, Edward Nemeth, David Martin. The calcium - sensing receptor : a key factor in the pathogenesis of sencondary hyper -parathyroidism [J]. AmJ Physiol Renal, 2005, 288 (2) : 253 - 264.
6Henley C, Colloton M, Cattley RC, et al. 1, 25 - Dihydroxyvitamin D3 , but not cinaealeet HCI ( Sensipar/Mimpara), treatment mediates aortie calcification in a rat model of secondary hyperparathyroidism [ J ]. Nephrol dial Transplant, 2006, 21 (2) : 1370.